Diabetes mellitus, and disorders of the lipid metabolism and the metabolic syndrome are major concomitant diseases found in patients with hypertension [14] . Because of these comorbidities, the use of multiple drugs is common and is recommended by international guidelines [14, 15] .
The aim of the present noninterventional study SIMPLIFY (Nicht-interventionelle 
MATERIALS AND METHODS

Study Design
The 
INTRODUCTION
Hypertension is one of the main risk factors for cardiovascular diseases [1] . Its prevalence has increased worldwide and is predicted to further increase [1, 2] . This situation is further complicated by the fact that a considerable percentage of patients with hypertension have not been diagnosed as such and are, thus, not under treatment. A large portion of treated patients do not reach target blood pressure [3] . The results of a meta-analysis of 147 randomized studies underline the importance of blood pressurelowering treatments. For each reduction by 10 mmHg in systolic blood pressure or by 5 mmHg in diastolic blood pressure, a 22% reduction in events due to coronary heart disease and a 41% reduction in stroke was observed [4] .
Results of controlled studies show that blood pressure adjustments to values below 140/90 mmHg are possible, even if two or more antihypertensive drugs are needed [5] [6] [7] [8] [9] . Another meta-analysis, using 63 studies (including 6 studies in hypertension) showed that patients with high adherence to their treatment schedule have a much higher chance to reach target blood pressure than patients with low adherence to treatment schedule (odds ratio [OR] 3.44; 95% confidence interval [CI] 1.60, 7.37). [10] . This confirms the important role of compliance/adherence in reaching the target blood pressure and in avoiding cardiovascular events [11] .
One factor that has a major influence on treatment compliance is the so-called pill burden,
i.e., the number of pills the patient needs to take per day. Studies have indicated that higher pill burden led to decreased treatment compliance [12, 13] .
In many cases, hypertension is not the only condition that a given patient suffers from.
questionnaire concerning the influence of the number of pills (nine items) and physicians filled in a questionnaire concerning the impact of the number of pills in daily practice (six items). Details on the questions are given in Table 1 . At the end of the study, effectiveness and tolerability was assessed by the physician.
Adverse events (AEs) were reported during the whole study according to local regulations.
It was the aim of the SIMPLIFY study to The data in all documentation forms were examined for their plausibility by the data management department. Additionally, for a defined percentage (2%, in line with common practice in Germany [16] ) of randomly chosen study centers, the documentation forms were compared with the source documents during on-site monitoring.
Data Analysis
According to the predefined statistical analysis plan, the statistical evaluation was carried out using basic descriptive statistical methods and was interpreted in an explorative way. In the publication, the results of the overall population is shown as well as analyses based on the number of pills. 
Study Population
Patients of either gender suffering from essential hypertension for whom treatment with A+V+H was indicated according to the physician's opinion were included into this noninterventional study. There were no additional inclusion criteria (e.g., severity of hypertension). There were no predefined e x c l u s i o n c r i t e r i a , e x c e p t f o r t h e contraindications mentioned in the respective summary of product characteristics (SmPC).
All dosages of A+V+H available in the German market could be used.
Study Conduct and Assessments
The observational period per patient was approximately 3-4 months. An examination was to be documented by the physician at the start and the end of the observation period.
Optionally, physicians could document an additional visit in between. At the start of the observational period, patients filled in a 
RESULTS
Baseline Characteristics
Patients were enrolled in 905 practices in Germany. For 7,181 patients, filled-in questionnaires were available. Of these, 7,101 patients were analyzed.
Slightly more than half of the patients were male and >60 years old. Only about a third of the patients reported diabetes mellitus (Table 2) . At the start of observation (before the physicians had changed the patients' medication to the singlepill triple therapy with A+V+H), the patients were taking 4.9 ± 3.1 pills (mean ± standard deviation
[SD]) per day for the treatment of any indication (median: 4.0 pills) and 3.1 ± 2.0 pills (mean ± SD)
per day of these for treatment of hypertension (median: 3.0 pills). Slightly more than a quarter of the patients were taking ≥6 pills (Table 3) .
Patient Questionnaire
Patients of either gender suffering from essential hypertension for whom treatment with A+V+H was indicated according to the 
Burden and Perception of Disease
When asked, the majority of patients stated that having to take several pills per day was a burden for them (Fig. 1 
Need for Assistance and Expenditure of Time
Concerning Management of Medication
The majority of patients (overall 85.7% of patients) stated that they did not need any help to prepare the intake of pills for the day/week at home (Table 1 , patient questionnaire, item 3).
The higher the number of pills, the more patients needed help, i.e., 22.8% needed help in patients with >6 pills a day, whereas only 6.1%
needed help in patients with ≤3 pills.
Approximately two thirds of the patients (62.6%) stated that the average time needed for the preparation of pill intake was 5 min or less.
The percentage of patients who needed more than 10 min for this task increased with increasing number of pills. A clear increase was seen between ≤3 pills and >3 pills: for ≤3 pills only 4.4% of patients needed more than 10 min, while for >3 pills, 10% of patients needed more than 10 min.
As expected, the percentage of patients who needed more than 10 min also increased with increasing age, reaching a value of 20.8% in >79 year olds.
Impact of Pill Color and Shape/Change of Compound
The color and shape of the pills appeared to play an important role as guidance for the intake of pills (Table 1 , patient questionnaire, item 5a) in the majority of patients (74.3%). In this context, the importance of color and shape increased with the number of pills that patients had to take. A total of 82.2% of the patients who were taking >6 pills considered color and shape an important landmark, in contrast to 67.6% of patients who were taking ≤3 pills.
Concerning age, the importance attributed to color and shape is higher in older (83.8% in Similarly, concern about medication errors is of higher relevance in older patients (≥80 year olds: 66.9%) than in younger patients (<50 year olds: 36.2%).
In fact, 59.3% of the patients admitted that they had already been uncertain at times whether they had already taken their pills or not. When asked how often this had happened, 56.9% answered that this had happened at least occasionally. Higher numbers of pills per day also lead to higher percentages of patients who claimed that they had often or occasionally been uncertain whether they had already taken their pills or not (≤3 pills per day: 6.1% often and 41.7% occasionally; >6 pills per day: 16.5% often and 48.6% occasionally). 18.0% defined 2 pills, and 18.3% defined 3 pills as the limit. About a quarter of patients (24.5%) stated that there was no limit.
Willingness to Make an Additional Out-of-
Pocket Payment
The fact that a high number of pills to be taken daily constitutes a massive burden for the patients is further highlighted by the fact that more than half of the patients (50.6%) would be willing to make additional out-ofpocket payments if this would result in having to take only half as many pills with the same standard of medical care. This statement was mostly independent of the actual pill burden and the age of the patients. In patients taking ≤3 pills, 46.1% would be willing to make additional payments, and in patients taking >6 pills, 54.2% would be willing to make additional payments.
When asked about the amount of money that they would be willing to pay additionally, most patients would be willing to pay up to 10 Euro (€) per month (see Fig. 4 ).
Subgroups
The results of the patient questionnaire were further evaluated with regard to specific subgroups by age, gender, and the presence of additional diseases, such as diabetes mellitus.
A number of subgroups showed a consistently higher level of agreement with the statements made in the questionnaire than other subgroups.
As already specified before, these were the elderly patients (especially those ≥80 years old), patients with a high pill burden, and patients suffering from diabetes mellitus. The patient questionnaire in the present study showed that patients consider having to take several pills per day a burden and that this also had an influence on how sick they feel. This was also corroborated by the physicians' questionnaire. The vast majority of physicians reported that in daily practice the chronically ill patients described the high number of pills a burden.
Physician Questionnaire
This effect is more pronounced in patients with a higher number of pills than in those with a lower number of pills. Elderly patients and patients suffering from diabetes mellitus are additional subgroups who seem to be more prone to regarding a high number of pills per day as a burden. This may be related to the fact that these subgroups may also be prone to having a higher pill burden than younger patients and patients not suffering from diabetes mellitus.
The present study also showed that the physicians were aware of the problems that are generally associated with the high pill burden and the effect it had on compliance. The vast majority of physicians stated that they were prepared to prescribe combinations in order to reduce the pill burden. Nevertheless, this seems to have little effect on daily practice as the patients were taking an average of 5 pills per day and more than a quarter of the patients were taking had not received training [17] , and that patients of trained physicians showed a significantly higher compliance than patients of physicians who had not been specially trained [18] .
In addition to the physician, patient compliance is also a key factor when it comes to the effectiveness of a therapeutic intervention.
Features that influence compliance are demographic characteristics, side effects of the therapy, how simple the intake of the medication is, costs of the medication, and the number of pills to be taken [19, 20] Index and in the number of Beers drugs per patient, and a significant reduction in the number of adverse drug events [26] . However, it was unclear if the intervention also resulted in a clinically significant improvement [26] .
Another approach, Good Palliative-Geriatric Practice algorithm for drug discontinuation, was developed by Garfinkel et al. in a prospective interventional study [27] . Successful discontinuation of drugs was achieved in 81% of patients. Of the discontinued drug therapies, 2% were restarted because of recurrence of the original indication. A total of 88% of patients reported global improvement in health.
However, this tool still needs to be tested in number of total pills daily or by age group. The number of patients was similar to the number that was used in the retrospective study on predictors of adherence with antihypertensive (and lipid-lowering) treatment in the US [12] .
CONCLUSION
In conclusion, a high number of pills is considered a burden by patients. This burden increases with the number of pills taken per day and needs to be actively addressed, especially in elderly patients and those with comorbidities.
Further research is necessary to evaluate which approaches may be most promising. 
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